Natural Capsules
Natural Capsules Ltd valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Natural Capsules Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Valuation
Profitability
Growth
Financial Health
Natural Capsules Ltd financials: P&L, balance sheet, cash flow, ratios.
Twelve years of audited numbers for Natural Capsules Ltd, switchable between annual and quarterly views, consolidated or standalone.
Natural Capsules Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹160.18 Cr and reported EPS of ₹-23.84.
| Period | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 60 | 62 | 80 | 135 | 172 | 155 | 169 | 187 |
| Other Income | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 |
| Total Income | 61 | 63 | 80 | 136 | 173 | 157 | 170 | 189 |
| Cost of Goods Sold (COGS) | 27 | 28 | 37 | 60 | 79 | 79 | 85 | 102 |
| Gross Profit | 33 | 34 | 42 | 75 | 94 | 77 | 84 | 85 |
| +Operating Expenses | 29 | 28 | 31 | 50 | 60 | 57 | 67 | 86 |
| EBITDA | 5 | 5 | 11 | 25 | 34 | 20 | 18 | -2 |
| +Non-Operating Expenses | 3 | 5 | 7 | 7 | 11 | 14 | 15 | 28 |
| Profit Before Tax (PBT) | 2 | 1 | 9 | 19 | 24 | 8 | 3 | -28 |
| +Tax Expense | 0 | 1 | 2 | 5 | 7 | 3 | 2 | -3 |
| Profit After Tax (PAT) | 2 | 1 | 7 | 14 | 18 | 6 | 1 | -25 |
| Earnings Per Share (EPS) | 2.05 | 0.92 | 7.39 | 14.89 | 18.79 | 5.94 | 0.60 | -16.44 |
| Diluted Shares Outstanding (Nos.) | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| +Additional Disclosures | 85 | 89 | 111 | 176 | 227 | 228 | 252 | 312 |
| Sales Growth % | — | 2.98 | 29.16 | 69.88 | 27.62 | -9.83 | 8.87 | 10.64 |
| YoY Sales Growth % | — | 2.98 | 29.16 | 69.88 | 27.62 | -9.83 | 8.87 | 10.64 |
| Material Cost % | 38 | 45 | 45 | 41 | 48 | 54 | 51 | 55 |
| Employee Cost % | 11 | 11 | 10 | 7 | 6 | 8 | 8 | 11 |
| Other Cost % | 37 | 34 | 29 | 30 | 28 | 29 | 31 | 35 |
| OPM % | 8 | 9 | 14 | 19 | 20 | 13 | 10 | -1 |
| Tax % | 7 | 37 | 25 | 28 | 27 | 31 | 78 | 12 |
| Profit Growth % | — | -55.21 | 703.49 | 101.45 | 26.22 | -68.41 | -88.88 | -4,094.72 |
| Gross Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 |
| Additional Fields | 2 | 1 | 7 | 20 | 27 | 11 | 8 | -19 |
Natural Capsules segment analysis: revenue and profit mix.
Disclosed business segments at Natural Capsules with their share of revenue and profit, switchable between consolidated and standalone reporting.
Natural Capsules discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
Natural Capsules Ltd investment thesis: bull case, bear case, and the flip lines.
Why someone would buy Natural Capsules Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.
What you're getting.
No strengths or opportunities on record.
What can break it.
No weaknesses or threats on record.
What would change my mind.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 49.70. Balance sheet risk re-prices growth multiples fast.
Natural Capsules Ltd peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Natural Capsules Ltd is highlighted for quick read-across.
Quick Compare
Peer Comparison
Natural Capsules Ltd technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Natural Capsules Ltd — derived from the live tape, not yesterday's close.
Natural Capsules Ltd last traded at ₹155.95 with an intraday range of ₹152.21–₹156.8 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹155.95| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 166.94 | +10.99 | +7.05% |
| R3 | 162.35 | +6.40 | +4.11% |
| R2 | 159.58 | +3.63 | +2.33% |
| R1 | 157.76 | +1.81 | +1.16% |
| PIVOT | 154.99 | -0.96 | -0.62% |
| CURRENT | 155.95 | — | — |
| S1 | 143.99 | -11.96 | -7.67% |
| S2 | 148.58 | -7.37 | -4.72% |
| S3 | 150.40 | -5.55 | -3.56% |
| S4 | 153.17 | -2.78 | -1.78% |
NATCAPSUQ is trading Above CPR, indicating Bullishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: 152.16 ~ 155.75
Trading Above opening range, showing Bullishness
Natural Capsules Ltd delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Natural Capsules Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Natural Capsules Ltd stood at 65.6% of traded volume, against a 20-day average of 75.9%.
Natural Capsules announcements: results, concalls, ratings, M&A.
Filings Natural Capsules sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Natural Capsules files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 73 documents below.
Disclosure under SEBI Takeover Regulations
Natural Capsules Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India…
General Updates
Natural Capsules Limited has informed the Exchange about General Updates
Analysts/Institutional Investor Meet/Con. Call Updates
Natural Capsules Limited has informed the Exchange about Schedule of meet
Copy of Newspaper Publication
Natural Capsules Limited has informed the Exchange about Copy of Newspaper Publication
Resignation of Director/KMP/SMP
Natural Capsules Limited has informed the Exchange about Resignation of Director/KMP/SMP
Investor decks & rating reports.
Natural Capsules dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Natural Capsules has declared, sequenced by announce and record date.
Natural Capsules corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Natural Capsules Ltd: business, sector, key facts.
What Natural Capsules Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Natural Capsules Ltd operates in the Healthcare, listed as NSE: NATCAPSUQ, BSE: 524654.
Natural Capsules Limited, operating under the assumed name NATCAPSUQ (although this name isn't explicitly stated in the provided text), is a prominent manufacturer and supplier of hard gelatin and cellulose capsule shells. Their primary market encompasses both India and international locations, showcasing a robust global presence in the pharmaceutical packaging industry. The company's offerings cater to a diverse range of customer needs and regulatory requirements.
The company’s product portfolio features a wide variety of capsule shells, demonstrating a commitment to providing options for diverse applications. This includes bovine spongiform encephalopathy (BSE) and transmissible spongiform encephalopathy (TSE)-free gelatin, which addresses critical safety concerns in pharmaceutical manufacturing. Additionally, they offer shiny gelatin for enhanced visual appeal, sodium lauryl sulfate-free gelatin for specific formulation needs, and halal-certified gelatin for compliance with religious dietary regulations. Further options include fast-release gelatin for expedited drug delivery and printed gelatin/cellulose capsules for branding and product identification. For customers seeking vegetarian alternatives, the company provides suitable cellulose capsule shells, and enteric capsules are also part of their extensive product line.
Beyond the production and sale of capsule shells, Natural Capsules Limited extends its services into pharmaceutical dosage form formulation. This vertical integration allows them to offer a comprehensive solution to clients, moving beyond simply supplying packaging materials to providing assistance in the complete creation of capsule-based medications. This aspect of their business suggests a deeper understanding of the pharmaceutical industry and the requirements for effective drug delivery.
Established in 1993 and headquartered in Bengaluru, India, Natural Capsules Limited boasts a significant history within the sector. Their export activities highlight their success in reaching international markets and competing effectively on a global scale. The company's continued operation and diverse product offerings suggest a strong market position and a commitment to innovation within the pharmaceutical packaging industry.
Questions investors ask about Natural Capsules Ltd (NATCAPSUQ).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Natural Capsules Ltd (NATCAPSUQ)?
The current share price of Natural Capsules Ltd (NATCAPSUQ) is ₹155.95. Today, the stock has gained by ₹2.41 (1.57%), trading in a range of ₹152.21 to ₹156.8. The stock opened at ₹155 with a trading volume of 2,372 shares.
02Is Natural Capsules Ltd stock a good investment for long-term?
Natural Capsules Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹160.18 crores, P/E ratio of 0.00, ROE of -10.03%, and ROCE of 2.67%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Natural Capsules Ltd stock?
The 52-week high price of Natural Capsules Ltd (NATCAPSUQ) is ₹0, while the 52-week low is ₹0. Currently trading at ₹155.95, the stock is Infinity% away from its 52-week low and -Infinity% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Natural Capsules Ltd stock at the current price?
Whether to buy Natural Capsules Ltd stock at ₹155.95 depends on multiple factors. The stock is currently trading with a P/E ratio of 0.00 and P/B ratio of 0.71. Today's performance shows a gain of 1.57%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Natural Capsules Ltd and when is the next dividend?
Natural Capsules Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹155.95, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Natural Capsules Ltd?
Natural Capsules Ltd's key financial metrics include: P/E Ratio: 0.00, P/B Ratio: 0.71, ROE: -10.03%, ROCE: 2.67%, Dividend Yield: 0.00%, EPS: ₹-23.84, Book Value: ₹219.3, and Debt-to-Equity: 49.20. The company's market cap stands at ₹160.18 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Natural Capsules Ltd stock performing today in the market?
Natural Capsules Ltd stock opened at ₹155 and is currently trading at ₹155.95, showing a gain of ₹2.41 (1.57%). The intraday high is ₹156.8 and low is ₹152.21. The trading volume stands at 2,372 shares, indicating moderate market participation today.
08What is the P/E ratio of Natural Capsules Ltd and what does it indicate?
Natural Capsules Ltd has a Price-to-Earnings (P/E) ratio of 0.00, which means investors are willing to pay ₹0.00 for every ₹1 of earnings. With an EPS of ₹-23.84, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Natural Capsules Ltd (NATCAPSUQ) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- 3B Blackbio DX (3BBLACKBIO) Share PricePeer
- Abbott India (ABBOTINDIA) Share PricePeer
- Acutaas Chemicals (ACUTAAS) Share PricePeer
- AHCL (AHCL) Share PricePeer
- AMANTA (AMANTA) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy